Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.

Xin H, Cartmell J, Bailey JJ, Dziadek S, Bundle DR, Cutler JE.

PLoS One. 2012;7(4):e35106. doi: 10.1371/journal.pone.0035106. Epub 2012 Apr 26.

2.

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Xin H, Cutler JE.

Clin Vaccine Immunol. 2011 Oct;18(10):1656-67. doi: 10.1128/CVI.05215-11. Epub 2011 Aug 10.

3.

Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.

Cutler JE, Corti M, Lambert P, Ferris M, Xin H.

PLoS One. 2011;6(7):e22030. doi: 10.1371/journal.pone.0022030. Epub 2011 Jul 19.

4.

Prospects for development of a vaccine to prevent and control vaginal candidiasis.

Fidel PL Jr, Cutler JE.

Curr Infect Dis Rep. 2011 Feb;13(1):102-7. doi: 10.1007/s11908-010-0143-y.

5.

Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Xin H, Dziadek S, Bundle DR, Cutler JE.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13526-31. doi: 10.1073/pnas.0803195105. Epub 2008 Aug 25.

6.

MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers.

Qian J, Cutler JE, Cole RB, Cai Y.

Anal Bioanal Chem. 2008 Oct;392(3):439-49. doi: 10.1007/s00216-008-2288-1. Epub 2008 Aug 9.

PMID:
18690424
7.

Advances in combating fungal diseases: vaccines on the threshold.

Cutler JE, Deepe GS Jr, Klein BS.

Nat Rev Microbiol. 2007 Jan;5(1):13-28. Epub 2006 Dec 11. Review.

9.

Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.

Wetter TJ, Hazen KC, Cutler JE.

Med Mycol. 2005 Sep;43(6):525-32. Erratum in: Med Mycol. 2006 May;44(3):293-4.

PMID:
16323310
10.

Defining criteria for anti-mannan antibodies to protect against candidiasis.

Cutler JE.

Curr Mol Med. 2005 Jun;5(4):383-92. Review.

PMID:
15977994
11.

Yeast wall protein 1 of Candida albicans.

Granger BL, Flenniken ML, Davis DA, Mitchell AP, Cutler JE.

Microbiology. 2005 May;151(Pt 5):1631-44.

PMID:
15870471
12.

Is a vaccine needed against Candida albicans?

Mochon AB, Cutler JE.

Med Mycol. 2005 Mar;43(2):97-115. Review. Erratum in: Med Mycol. 2006 Mar;44(2):197.

PMID:
15832554
13.

Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition.

Hobson RP, Munro CA, Bates S, MacCallum DM, Cutler JE, Heinsbroek SE, Brown GD, Odds FC, Gow NA.

J Biol Chem. 2004 Sep 17;279(38):39628-35. Epub 2004 Jul 22.

14.
15.

The role of the Candida albicans histidine kinase [CHK1) gene in the regulation of cell wall mannan and glucan biosynthesis.

Kruppa M, Goins T, Cutler JE, Lowman D, Williams D, Chauhan N, Menon V, Singh P, Li D, Calderone R.

FEMS Yeast Res. 2003 May;3(3):289-99. Erratum in: FEMS Yeast Res. 2003 Oct;4(1):125.

16.
18.

Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway.

Fu Y, Ibrahim AS, Sheppard DC, Chen YC, French SW, Cutler JE, Filler SG, Edwards JE Jr.

Mol Microbiol. 2002 Apr;44(1):61-72.

19.

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

Bacci A, Montagnoli C, Perruccio K, Bozza S, Gaziano R, Pitzurra L, Velardi A, d'Ostiani CF, Cutler JE, Romani L.

J Immunol. 2002 Mar 15;168(6):2904-13.

20.

N-glycosylation of yeast, with emphasis on Candida albicans.

Cutler JE.

Med Mycol. 2001;39 Suppl 1:75-86. Review.

PMID:
11800271
21.

The unique solution structure and immunochemistry of the Candida albicans beta -1,2-mannopyranan cell wall antigens.

Nitz M, Ling CC, Otter A, Cutler JE, Bundle DR.

J Biol Chem. 2002 Feb 1;277(5):3440-6. Epub 2001 Nov 7.

22.

In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages.

Grinsell M, Weinhold LC, Cutler JE, Han Y, Kozel TR.

J Infect Dis. 2001 Aug 15;184(4):479-87. Epub 2001 Jul 13.

PMID:
11471106
23.
24.

Inhibition of hydrophobic protein-mediated Candida albicans attachment to endothelial cells during physiologic shear flow.

Glee PM, Cutler JE, Benson EE, Bargatze RF, Hazen KC.

Infect Immun. 2001 May;69(5):2815-20.

25.

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G.

Med Mycol. 2000;38 Suppl 1:281-92. Review.

PMID:
11204156
27.

Analysis of surface antigen expression and host defense function in leukocytes from calves heterozygous or homozygous for bovine leukocyte adhesion deficiency.

Sipes KM, Edens HA, Kehrli ME Jr, Miettinen HM, Cutler JE, Jutila MA, Quinn MT.

Am J Vet Res. 1999 Oct;60(10):1255-61.

PMID:
10791939
29.

Determination of antifungal MICs by a rapid susceptibility assay.

Riesselman MH, Hazen KC, Cutler JE.

J Clin Microbiol. 2000 Jan;38(1):333-40.

30.

Peptide ligands that bind IgM antibodies and block interaction with antigen.

Glee PM, Pincus SH, McNamer DK, Smith MJ, Burritt JB, Cutler JE.

J Immunol. 1999 Jul 15;163(2):826-33.

31.
33.

Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?

Casadevall A, Cassone A, Bistoni F, Cutler JE, Magliani W, Murphy JW, Polonelli L, Romani L.

Med Mycol. 1998;36 Suppl 1:95-105. Review.

PMID:
9988497
36.
37.

The Candida albicans phosphomannan complex in Candida-host interactions.

Cutler JE.

Res Immunol. 1998 May-Jun;149(4-5):299-308; discussion 507-9. Review. No abstract available.

PMID:
9720948
38.

Candida albicans hyphal formation and virulence: is there a clearly defined role?

Kobayashi SD, Cutler JE.

Trends Microbiol. 1998 Mar;6(3):92-4. No abstract available.

PMID:
9582930
39.
40.
41.
42.
43.

Antibody response that protects against disseminated candidiasis.

Han Y, Cutler JE.

Infect Immun. 1995 Jul;63(7):2714-9.

44.

Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis.

Qian Q, Jutila MA, Van Rooijen N, Cutler JE.

J Immunol. 1994 May 15;152(10):5000-8.

PMID:
8176217
45.

Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions.

Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, McAnulty JH.

JAMA. 1994 May 4;271(17):1335-9.

PMID:
8158818
46.

Mouse sialoadhesin is not responsible for Candida albicans yeast cell binding to splenic marginal zone macrophages.

Han Y, Kelm S, Riesselman MH, Crocker PR, Cutler JE.

Infect Immun. 1994 May;62(5):2115-8.

48.

Chemical definition of an epitope/adhesin molecule on Candida albicans.

Li RK, Cutler JE.

J Biol Chem. 1993 Aug 25;268(24):18293-9.

49.
50.

Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue.

Kanbe T, Han Y, Redgrave B, Riesselman MH, Cutler JE.

Infect Immun. 1993 Jun;61(6):2578-84.

Supplemental Content

Loading ...
Support Center